Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Metastatic Melanoma · Unresectable Melanoma · IOVA

Iovance Biotherapeutics

Iovance Biotherapeutics B.V.

Iovance Biotherapeutics trial registry — 37 ClinicalTrials.gov studies with program phase, status, and indication context.

Website Investor relations
825 Industrial Rd, Suite 400, San Carlos, California 94070, US HQ
2007 Founded
916 Employees
Public company Type
IOVA · NYSE Ticker
Company details
Status
Public
HQ
825 Industrial Rd, Suite 400, San Carlos, California 94070, US
Founded
2007
Employees
916
Programs
36
Drugs
26
Patents
94
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Trials

Iovance Biotherapeutics clinical trials

Registry index of 37 ClinicalTrials.gov studies linked to Iovance Biotherapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Iovance Biotherapeutics trial registry — 37 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Iovance Biotherapeutics.

  1. IOV-MEL-301 — Phase 3

    Clinical update

  2. IOV-LUN-202 — Phase 2

    Clinical update

  3. C-145-04 — Phase 2

    Clinical update

  4. IOV-MEL-202 — Phase 2

    Clinical update

  5. IOV-COM-202 — Phase 2

    Clinical update

  6. Tumor infiltrating lymphocytes (TIL) LN-145 — Phase 2

    Clinical update

  7. TIL — Phase 1

    Clinical update

  8. locally manufactured adoptive cellular therapy (ACT) product — Phase 1

    Clinical update

Trial registry

37 studies

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.